EUVIMEDEUVIMED entdecken
Crossref

The Prevalence of Inflammatory Bowel Disease in Juvenile Spondyloarthritis

Ipek Ulkersoy iD, Umit Gul iD, Mehmet Yildiz iD, Arlin Tunc iD, Sevval Ozyildirim iD, Nergis Akay iD, Oguzhan Tin iD, Nursena Kologlu Ates iD, Elif Kilic Konte iD, Aybuke Gunalp iD, Esma Aslan iD, Ayse Kalyoncu Ucar iD und 7 weitere

Journal of Digestive Diseases · 2025

DOI: 10.1111/1751-2980.70028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Digestive Diseases, 2025. Verfasst von Ipek Ulkersoy und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Gastroenterology, Hepatology and Nutrition, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Spondylarthritis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Juvenile spondyloarthritis (JSpA) shares genetic, immunopathogenic, and environmental features with pediatric inflammatory bowel disease (IBD), placing patients at an elevated risk for IBD. We aimed to evaluate the prevalence of IBD and identify potential early markers for its recognition in children with JSpA, trying to improve its diagnostic, screening, and treatment strategies.

Methods

Children diagnosed with JSpA were prospectively evaluated. Fecal calprotectin (FCP) was measured in all participants, and those with elevated FCP (> 100 μg/g) or two or more IBD‐related symptoms (chronic diarrhea, weight loss/growth retardation, abdominal pain, or bloody/mucous stool) underwent ileocolonoscopy with histopathological and radiological assessment.

Results

Altogether 81 children (71.6% male) with a mean age of 194 months at adimission were included, and 23 underwent endoscopic evaluation (19 for elevated FCP, 4 for two or more IBD‐related symptoms). Among them, 10 (43.5%) had both macroscopic and microscopic presentation of colitis, 4 (17.4%) had microscopic appearance only, and 9 (39.1%) had normal histopathological findings. Notably, 94.7% of children with elevated FCP levels were asymptomatic for IBD. Among FCP‐positive patients, 13 (68.4%) showed macroscopic and/or microscopic mucosal changes. Overall, colitis was confirmed in 14 (17.3%) patients. Sacroiliitis, as confirmed by magnetic resonance imaging, was significantly more frequent among both FCP‐positive and colitis‐positive patients ( p < 0.001 and p = 0.008, respectively). No significant associations were found between FCP levels or intestinal inflammation and disease activity, acute‐phase reactants, or treatment status.

Conclusions

IBD and subclinical colitis are relatively frequent in JSpA. Elevated FCP represents a promising noninvasive biomarker for detecting silent intestinal inflammation, warranting confirmation by ileocolonoscopy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesSpondylarthritisHumansMaleFemaleChildPrevalenceLeukocyte L1 Antigen ComplexFecesAdolescentProspective StudiesBiomarkersColonoscopyChild, Preschool

Stichwörter der Autor:innen

colitisfecal calprotectininflammatory bowel diseasesjuvenile spondyloarthritisscreening

Substanzen

Leukocyte L1 Antigen ComplexBiomarkers

Autor:innen und Institutionen

  • Department of Pediatric Gastroenterology, Hepatology and Nutrition, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Department of Pediatric Rheumatology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Department of Pediatrics, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Department of Pediatric Radiology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Department of Pathology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Department of Pediatric Gastroenterology, Hepatology and Nutrition, Cerrahpasa Faculty of Medicine, Demiroglu Bilim University, Istanbul, Turkey.

ORCID-Profile: Ipek Ulkersoy, Umit Gul, Mehmet Yildiz, Arlin Tunc, Sevval Ozyildirim, Nergis Akay, Oguzhan Tin, Nursena Kologlu Ates, Elif Kilic Konte, Aybuke Gunalp, Esma Aslan, Ayse Kalyoncu Ucar, Sezgin Sahin, Nuray Kepil, Kenan Barut, Omer Faruk Beser, Sebuh Kurugoglu, Fugen Cullu Cokugras, Ozgur Kasapcopur

Zitieren

APA

Ulkersoy, I., Gul, U., Yildiz, M., Tunc, A., Ozyildirim, S., Akay, N., Tin, O., Ates, N. K., Konte, E. K., Gunalp, A., Aslan, E., Ucar, A. K., Sahin, S., Kepil, N., Barut, K., Beser, O. F., Kurugoglu, S., Cokugras, F. C., & Kasapcopur, O. (2025). The Prevalence of Inflammatory Bowel Disease in Juvenile Spondyloarthritis. Journal of Digestive Diseases. https://doi.org/10.1111/1751-2980.70028

Vancouver

Ulkersoy I, Gul U, Yildiz M, Tunc A, Ozyildirim S, Akay N, et al. The Prevalence of Inflammatory Bowel Disease in Juvenile Spondyloarthritis. Journal of Digestive Diseases. 2025. doi:10.1111/1751-2980.70028

BibTeX
@article{Ulkersoy2025,
  author = {Ulkersoy, Ipek and Gul, Umit and Yildiz, Mehmet and Tunc, Arlin and Ozyildirim, Sevval and Akay, Nergis and Tin, Oguzhan and Ates, Nursena Kologlu and Konte, Elif Kilic and Gunalp, Aybuke and Aslan, Esma and Ucar, Ayse Kalyoncu and Sahin, Sezgin and Kepil, Nuray and Barut, Kenan and Beser, Omer Faruk and Kurugoglu, Sebuh and Cokugras, Fugen Cullu and Kasapcopur, Ozgur},
  title = {The Prevalence of Inflammatory Bowel Disease in Juvenile Spondyloarthritis},
  journal = {Journal of Digestive Diseases},
  year = {2025},
  doi = {10.1111/1751-2980.70028}
}
Kostenlos starten →